Trial Profile
The Effect of Intranasal Application of Anti-IgE Antibodies on IgE Production in Patients Suffering From Seasonal Allergic Rhinitis - a Pilot Study
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Omalizumab (Primary) ; Birch pollen allergy immunotherapy
- Indications Allergic rhinitis
- Focus Therapeutic Use
- 17 Jan 2017 New trial record